News
ZLAB
18.77
-1.37%
-0.26
Zai Lab’s ZL-6201 Study Advances in Sarcoma and Solid Tumors: What Investors Should Watch
TipRanks · 15h ago
FDA Approves Optune Pax for Locally Advanced Pancreatic Cancer After Positive Phase 3 Results
Reuters · 1d ago
Zai Lab Ltd. hat eine Aktualisierung ihres Finanzkalenders veröffentlicht
Reuters · 2d ago
Zai Lab Ltd. to Announce Fourth Quarter and Full Year Financial Results
Reuters · 2d ago
Zai Lab to Announce Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates on February 26, 2026
Barchart · 3d ago
Bernstein Keeps Their Hold Rating on Zai Lab Ltd (1ZLB)
TipRanks · 3d ago
Weekly Report: what happened at ZLAB last week (0202-0206)?
Weekly Report · 3d ago
Zai Lab Is Maintained at Overweight by JP Morgan
Dow Jones · 02/05 18:52
Zai Lab Price Target Cut to $39.00/Share From $46.00 by JP Morgan
Dow Jones · 02/05 18:52
JP Morgan Maintains Overweight on Zai Lab, Lowers Price Target to $39
Benzinga · 02/05 18:43
NovoCure projects $13M monthly revenue hit as Medicare revokes billing privileges
Seeking Alpha · 02/05 15:03
Zai Lab price target lowered to $39 from $46 at JPMorgan
TipRanks · 02/05 13:36
$207B Market Shift: The Race for Fast Track Approval in Oncology
Barchart · 02/05 08:35
ClearBridge International Growth ADR Strategy exits Linde, adds Roche in Q4 2025
Seeking Alpha · 02/04 18:32
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains This Quarter
Benzinga · 02/03 11:23
SPDB Reaffirms Their Buy Rating on Zai Lab Ltd (1ZLB)
TipRanks · 02/03 05:06
Weekly Report: what happened at ZLAB last week (0126-0130)?
Weekly Report · 02/02 09:46
Zai Lab Ltd (1ZLB) Gets a Buy from Guotai Haitong
TipRanks · 01/30 05:19
Weekly Report: what happened at ZLAB last week (0119-0123)?
Weekly Report · 01/26 09:47
Weekly Report: what happened at ZLAB last week (0112-0116)?
Weekly Report · 01/19 09:50
More
Webull provides a variety of real-time ZLAB stock news. You can receive the latest news about Zai Lab Limited through multiple platforms. This information may help you make smarter investment decisions.
About ZLAB
Zai Lab Ltd is a holding company primarily engaged in biopharmaceutical business. The Company is focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. The Company has a series of patented drug candidates from the discovery stage to the late clinical project, including ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others. The Company conducts its businesses within domestic and overseas markets.